This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ACHN-975
Description: ACHN-975 is a first-in-class LpxC inhibitor. It addresses a target important for cell membrane formation in Gram-(-) bacteria, most notably Pseudomonas.
Additional information available to subscribers only: